MedTrace Logo

A Study to Evaluate the Mass Balance of [14C]SHR2554 in Healthy Adult Volunteers

NCT06010680 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2024-02-01

No results posted yet for this study

Summary

Evaluate the Mass Balance of \[14C\]SHR2554 in Healthy Adult Male Volunteers.

Conditions

Interventions

DRUG

[14C]SHR2554

Patients will receive single dose of orally \[14C\]SHR2554 on Day 1.

Sponsors & Collaborators

  • Jiangsu HengRui Medicine Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-07
Primary Completion
2023-11-27
Completion
2023-11-27

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06010680 on ClinicalTrials.gov